Pharmacologically Induced Hypogonadism and Sexual Function in Healthy Young Women and Men

被引:0
作者
Peter J Schmidt
Emma M Steinberg
Paula Palladino Negro
Nazli Haq
Carolyn Gibson
David R Rubinow
机构
[1] Behavioral Endocrinology Branch,Department of Psychiatry
[2] National Institute of Mental Health,undefined
[3] NIH,undefined
[4] DHHS,undefined
[5] University of North Carolina,undefined
来源
Neuropsychopharmacology | 2009年 / 34卷
关键词
sexual function; hypogonadism; estradiol; progesterone; testosterone; GnRH agonist;
D O I
暂无
中图分类号
学科分类号
摘要
Studies fail to find uniform effects of age-related or induced hypogonadism on human sexual function. We examined the effects of induced hypogonadism on sexual function in healthy men and women and attempted to identify predictors of the sexual response to induced hypogonadism or hormone addback. The study design used was a double-blind, controlled, crossover (self-as-own control). The study setting was an ambulatory care clinic in a research hospital, and the participants were 20 men (average±SD age=28.5±6.2 years) and 20 women (average±SD age=33.5±8.7 years), all healthy and with no history of psychiatric illness. A multidimensional scale assessing several domains of sexual function was the main outcome measure. Participants of the study received depot leuprolide acetate (Lupron) every 4 weeks for 3 months (men) or 5 months (women). After the first month of Lupron alone, men received (in addition to Lupron) testosterone enanthate (200 mg intramuscularly) or placebo every 2 weeks for 1 month each. Women received Lupron alone for 2 months, and then, in addition to Lupron, they received estradiol and progesterone for 5 weeks each. The results of the study: in women, hypogonadism resulted in a significant decrease in global measures of sexual functioning, principally reflecting a significant decrease in the reported quality of orgasm. In men, hypogonadism resulted in significant reductions in all measured domains of sexual function. Testosterone restored sexual functioning scores in men to those seen at baseline, whereas neither estradiol nor progesterone significantly improved the reduced sexual functioning associated with hypogonadism in women. Induced hypogonadism decreased sexual function in a similar number of men and women. No predictors of response were identified except for levels of sexual function at baseline. In conclusion, our data do not support a simple deficiency model for the role of gonadal steroids in human sexual function; moreover, while variable, the role of testosterone in sexual function in men is more apparent than that of estradiol or progesterone in women.
引用
收藏
页码:565 / 576
页数:11
相关论文
共 402 条
  • [1] Abraham GE(1972)Chromatographic separation of steroid hormones for use in radioimmunoassay Anal Lett 5 509-517
  • [2] Buster JD(1978)Rise in female-initiated sexual activity at ovulation and its suppression by oral contraceptives N Engl J Med 299 1145-1150
  • [3] Lucas LA(2004)The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials Menopause 11 749-765
  • [4] Corrales PC(1999)7α-Methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men J Clin Endocrinol Metab 84 3556-3562
  • [5] Teller RC(1999)Dehydroepiandrosterone replacement in women with adrenal insufficiency N Engl J Med 341 1013-1020
  • [6] Adams DB(1985)Correlates of sexual desire in post-menopausal women Maturitas 7 211-216
  • [7] Gold AR(1994)Effects of endogenous testosterone and estradiol on sexual behavior in normal young men J Clin Endocrinol Metab 78 711-716
  • [8] Burt AD(1980)Androgens and sexual behaviour in women using oral contraceptives Clin Endocrinol 12 327-340
  • [9] Alexander JL(2005)Relationship between serum sex steroids and aging male symptoms score and international index of erectile function Urology 66 597-601
  • [10] Kotz K(2002)Long-term effects of androgen deprivation therapy in prostate cancer patients Clin Endocrinol 56 779-786